Physician profile
Robert J Fuchs
NPI 1548377674
$16,165.41
in general payments reported to CMS, 2019-2025
8 companies · $4,168 in 2025
The $4,168 reported for 2025 was more than what 99% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $640 · 2020: $222 · 2021: $2,912 · 2022: $727 · 2023: $4,322 · 2024: $3,174 · 2025: $4,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $11K · Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $11,232.61 |
| Food and Beverage | $431.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $14,016.57 | 2021-2025 | Opalescence |
| A-Dec, INC. | $750.00 | 2021 | |
| Dentsply Sirona INC | $598.61 | 2019-2023 | Orthophos E |
| Midmark Corporation | $565.40 | 2019 | |
| Coltene Whaledent INC. | $138.02 | 2023 | |
| Planmeca USA, INC. | $57.07 | 2022 | |
| Voco America INC. | $21.51 | 2023-2025 | Futurabond U, Grandio So, Admira Fusion X-Tra |
| Envista Holdings Corporation | $18.23 | 2025 | Zirconia Abutment Preparation Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fuchs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.